Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.10%136.85M | -11.83%127.7M | -23.81%125.53M | -8.52%594.71M | -27.96%145.34M | -11.74%139.78M | 5.06%144.83M | 8.31%164.76M | 25.91%650.11M | 8.04%201.75M |
| Cost of revenue | -7.89%536.98M | 21.60%582.97M | ||||||||
| Gross profit | -14.01%57.74M | 81.95%67.15M | ||||||||
| Operating expense | -5.43%134.28M | -11.30%126.84M | -20.23%126.27M | 11.68%32.57M | -27.78%140.02M | -8.82%141.99M | 3.53%142.99M | 6.35%158.28M | -7.32%29.16M | 165.14%193.88M |
| Selling and administrative expenses | ---- | ---- | ---- | 2.63%48.86M | ---- | ---- | ---- | ---- | 28.89%47.61M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -1.10%5.85M | ---- | ---- | ---- | ---- | 24.99%5.91M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 3.16%43.01M | ---- | ---- | ---- | ---- | 29.46%41.7M | ---- |
| Depreciation and amortization | 9.20%6.46M | 2.49%6.5M | -9.30%6.72M | -2.02%26.37M | -9.53%6.7M | -16.73%5.92M | 5.02%6.34M | 16.50%7.41M | --26.91M | --7.41M |
| -Depreciation | 9.20%6.46M | 2.49%6.5M | -9.30%6.72M | -2.02%26.37M | -9.53%6.7M | -16.73%5.92M | 5.02%6.34M | 16.50%7.41M | --26.91M | --7.41M |
| Other operating expenses | -6.07%127.82M | -11.94%120.33M | -20.76%119.55M | -127.18%-2.05M | -28.50%133.32M | -9.41%136.07M | 3.46%136.65M | 5.90%150.87M | 1,483.02%7.55M | 160.37%186.47M |
| Total other operating income | ---- | ---- | ---- | -45.23%14.24M | ---- | 102.34%3.21M | ---- | ---- | 337.17%25.99M | ---- |
| Operating profit | 216.83%2.58M | -53.07%864K | -111.36%-737K | -33.74%25.17M | -32.47%5.31M | -182.74%-2.21M | 808.08%1.84M | 96.66%6.49M | 598.69%37.98M | 58.82%7.87M |
| Net non-operating interest income (expenses) | 3.00%-2.75M | 19.04%-2.32M | 35.31%-1.85M | -1.31%-11.37M | 7.88%-2.81M | -26.20%-2.84M | -3.62%-2.86M | 9.54%-2.86M | -43.30%-11.22M | -44.29%-3.05M |
| Non-operating interest income | 91.11%86K | 118.06%157K | 58.14%136K | -23.12%419K | 188.00%216K | -53.61%45K | -80.22%72K | 855.56%86K | 350.41%545K | -3.85%75K |
| Non-operating interest expense | -1.53%2.84M | -15.67%2.48M | -32.59%1.99M | 0.18%11.79M | -3.17%3.02M | 22.90%2.88M | -6.14%2.94M | -7.09%2.95M | 47.98%11.77M | 42.58%3.12M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 68.33%707K | -91.92%56K | -81.04%157K | -18.29%2.19M | -63.58%252K | -43.55%420K | 28.10%693K | 17.11%828K | 86.91%2.68M | 29.59%692K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -21.68%2.51M | -26.34%1.92M | -4.03%2.98M | -45.23%14.24M | -5.58%5.33M | 3.21M | 11.52%2.6M | 11.19%3.1M | 25.99M | 5.64M |
| Income before tax | 314.61%3.04M | -77.14%520K | -92.80%544K | -45.70%15.99M | -27.52%8.09M | -222.05%-1.42M | -83.15%2.28M | 108.10%7.55M | 1,802.89%29.44M | 2,664.37%11.16M |
| Income tax | 135.01%1.08M | 213.97%457K | -100.19%-6K | -115.40%-1.42M | -112.94%-1.06M | -508.10%-3.07M | -327.84%-401K | 3,746.91%3.12M | 533.36%9.22M | 400.26%8.21M |
| Net income | 18.66%1.97M | -97.65%63K | -87.60%550K | -13.91%17.41M | 210.84%9.15M | 305.88%1.66M | -79.91%2.68M | 25.03%4.44M | 4,967.92%20.22M | 27.96%2.94M |
| Net income continuous operations | 18.66%1.97M | -97.65%63K | -87.60%550K | -13.91%17.41M | 210.84%9.15M | 305.88%1.66M | -79.91%2.68M | 25.03%4.44M | 4,967.92%20.22M | 27.96%2.94M |
| Noncontrolling interests | 117.87%42K | 1.38%-214K | -65.44%-225K | -633.80%-1.04M | -219.72%-454K | -235K | -217K | -136K | -142K | -142K |
| Net income attributable to the company | 1.69%1.92M | -90.43%277K | -83.05%775K | -9.39%18.45M | 211.25%9.6M | 363.48%1.89M | -78.28%2.89M | 28.86%4.57M | 5,003.51%20.36M | 34.13%3.09M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.69%1.92M | -90.43%277K | -83.05%775K | -9.39%18.45M | 211.25%9.6M | 363.48%1.89M | -78.28%2.89M | 28.86%4.57M | 5,003.51%20.36M | 34.13%3.09M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -22.09%0.0067 | -92.37%0.001 | -87.02%0.0027 | -10.87%0.082 | 203.57%0.0425 | 352.63%0.0086 | -78.84%0.0131 | 23.08%0.0208 | 4,500.00%0.092 | 23.89%0.014 |
| Diluted earnings per share | -22.09%0.0067 | -92.37%0.001 | -87.02%0.0027 | -10.87%0.082 | 203.57%0.0425 | 352.63%0.0086 | -78.84%0.0131 | 23.08%0.0208 | 4,500.00%0.092 | 34.09%0.014 |
| Dividend per share | 0 | 0.0048 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.